Cadrenal Therapeutics, Inc. (CVKD) Net income 2023–2025
Cadrenal Therapeutics, Inc. (CVKD) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$13.2MFY2025 · since FY2023: -$8.4M → -$13.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.2M | -24.3% |
| FY2024 | -$10.7M | -27.5% |
| FY2023 | -$8.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CVKD financial trends
CVKD RevenueCVKD Net marginCVKD Gross profitCVKD Gross marginCVKD Operating incomeCVKD Operating marginCVKD Operating cash flowCVKD Free cash flowCVKD Capital expendituresCVKD Return on equityCVKD Stock buybacksCVKD Dividends paidCVKD Total assetsCVKD Total liabilitiesCVKD Shareholders’ equityCVKD overview →